Dublin, Feb. 12, 2020 (GLOBE NEWSWIRE) -- The "Acute Agitation and Aggression Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027" report has been added to ResearchAndMarkets.com's offering
This comprehensive business study analyzes and discusses Porter's Five Forces, with a latent aim to provide the key growth strategies available in the acute agitation and aggression treatment market during the forecast period. This comprehensive guide provides key insights regarding the competition present in the acute agitation and aggression treatment market by identifying key competitors. This report also offers information about the key strategies, financials, and notable developments of the acute agitation and aggression treatment market during the forecast period of 2019-2027.
Key questions answered in this report are:
- What are the recent developments and key market shifts expected to be witnessed in the acute agitation and aggression treatment market during the forecast period?
- What are the key winning imperatives for leading and prominent players operating in the acute agitation and aggression treatment market?
- What are the key trends propelling the growth of the acute agitation and aggression treatment market?
- Which end user will exert a strong influence on the acute agitation and aggression treatment market?
Key Topics Covered:
1 Preface
2 Assumptions and Acronyms
3 Research Methodology
4 Executive Summary
5 Market Overview
5.1 Product Overview
5.2 Market Dynamics
6 Global Acute Agitation and Aggression Treatment Market Analysis, by Drug Class
6.1 Introduction
6.2 Market Value Share Analysis, by Drug Class
6.3 Market Value Forecast, by Drug Class, 2017-2027
6.4 Market Attractiveness, by Drug Class
7 Global Acute Agitation and Aggression Treatment Market Analysis, by Route of Administration
7.1 Introduction
7.2 Market Value Share Analysis, by Route of Administration
7.3 Market Value Forecast, by Route of Administration, 2017-2027
7.4 Market Attractiveness, by Route of Administration
8 Global Acute Agitation and Aggression Treatment Market Analysis, by Indication
8.1 Introduction
8.2 Market Value Share Analysis, by Indication
8.3 Market Value Forecast, by Indication, 2017-2027
8.4 Market Attractiveness, by Indication
9 Global Acute Agitation and Aggression Treatment Market Analysis, by End-user
9.1 Introduction
9.2 Market Value Share Analysis, by End-user
9.3 Market Value Forecast, by End-user, 2017-2027
9.4 Market Attractiveness, by End-user
10 Global Acute Agitation and Aggression Treatment Market Analysis, by Region
10.1 Regional Outlook
10.2 Global Scenario
10.3 Introduction
10.4 Market Value Share Analysis, by Region
10.5 Market Attractiveness Analysis, by Region
11 North America Acute Agitation and Aggression Treatment Market Analysis
11.1 Key Findings
11.2 Market Value Forecast, by Country, 2017-2027
11.3 Market Value Forecast, by Drug Class, 2017-2027
11.4 Market Value Forecast, by Route of Administration, 2017-2027
11.5 Market Value Forecast, by Indication, 2017-2027
11.6 Market Value Forecast, by End-user, 2017-2027
11.7 Market Attractiveness Analysis
12 Europe Acute Agitation and Aggression Treatment Market Analysis
12.1 Key Findings
12.2 Market Value Forecast, by Country/Sub-region, 2017-2027
12.3 Market Value Forecast, by Drug Class, 2017-2027
12.4 Market Value Forecast, by Route of Administration, 2017-2027
12.5 Market Value Forecast, by Indication, 2017-2027
12.6 Market Value Forecast, by End-user, 2017-2027
12.7 Market Attractiveness Analysis
13 Asia Pacific Acute Agitation and Aggression Treatment Market Analysis
13.1 Key Findings
13.2 Market Value Forecast, by Country/Sub-region, 2017-2027
13.3 Market Value Forecast, by Drug Class, 2017-2027
13.4 Market Value Forecast, by Route of Administration, 2017-2027
13.5 Market Value Forecast, by Indication, 2017-2027
13.6 Market Value Forecast, by End-user, 2017-2027
13.7 Market Attractiveness Analysis
14 Latin America Acute Agitation and Aggression Treatment Market Analysis
14.1 Key Findings
14.2 Market Value Forecast, by Country/Sub-region, 2017-2027
14.3 Market Value Forecast, by Drug Class, 2017-2027
14.4 Market Value Forecast, by Route of Administration, 2017-2027
14.5 Market Value Forecast, by Indication, 2017-2027
14.6 Market Value Forecast, by End-user, 2017-2027
14.7 Market Attractiveness Analysis
15 Middle East & Africa Acute Agitation and Aggression Treatment Market Analysis
15.1 Key Findings
15.2 Market Value Forecast, by Country/Sub-region, 2017-2027
15.3 Market Value Forecast, by Drug Class, 2017-2027
15.4 Market Value Forecast, by Route of Administration, 2017-2027
15.5 Market Value Forecast, by Indication, 2017-2027
15.6 Market Value Forecast, by End-user, 2017-2027
15.7 Market Attractiveness Analysis
16 Company Profiles
- Eli Lilly and Company
- Pfizer, Inc.
- Ono Pharmaceutical Co., Ltd.
- Otsuka Holdings Co., Ltd.
- GlaxoSmithKline plc
- Bristol-Myers Squibb Company
- Janssen Biotech, Inc. (Johnson & Johnson)
- H. Lundbeck A/S
For more information about this report visit https://www.researchandmarkets.com/r/7lt74y
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.